Search results
Results from the WOW.Com Content Network
“According to the latest research study, the demand of US Biotechnology Market size & share was valued at approximately USD 533.4 Billion in 2023 and is expected to reach USD 583.8 Billion in 2024 and is expected to reach a value of around USD 1797.8 Billion by 2033, at a compound annual growth rate (CAGR) of about 12.3% during the forecast ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Westford, USA, Nov. 22, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the agricultural biotechnology market size will attain a value of USD 227.77 billion by 2031, with a CAGR of 8.8% over the forecast period (2024-2031).
[12] [13] Had this transaction been completed, this would have been the largest within this industry. 2 2014 Pfizer: Astra Zeneca: 123 158 Significant concerns were raised by the UK Government over job security, in the end leading to a deal being abandoned due to resistance from the AstraZeneca Board. [14] 3 2014 Pfizer: Astra Zeneca: 106 137
The natural fibre textile industry is based on cotton, linen, bamboo, hemp, wool, silk, angora, mohair and cashmere. [ 138 ] Activities related to textile production and processing that more clearly fall under the domain of the bioeconomy are developments such as the biofabrication of leather-like material using fungi, [ 139 ] [ 140 ] [ 141 ...
The industry produces over 60,000 generic drugs in different 60 therapeutic categories. [8] India's revenue from pharmaceutical exports was $25.3 billion in the 2022-2023 financial year. [7] In terms of the global market, India currently holds an accountable share and is known as the pharmacy of the world. [9]
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California, wholly owned by the Swiss multinational pharmaceutical company, the Roche Group. It became an independent subsidiary of Roche in 2009.